🔎 Trials Near Me

홈 › 미만성 거대 B세포 림프종 › 인디애나

인디애나의 미만성 거대 B세포 림프종 임상 시험

미만성 거대 B세포 림프종 관련 연구 9개가 인디애나 내 여러 지역에서 참여자를 모집하고 있습니다.

인디애나의 도시

공식 연구 텍스트(영어)

Testing the Effectiveness of a Combination Targeted Therapy (ViPOR) for Patients With Relapsed and/or Refractory Aggressive B-cell Lymphoma

  • Northwest Cancer Center - Crown Point, Crown Point
  • Northwest Oncology LLC, Dyer
  • Saint Mary Medical Center, Hobart
  • 외 4개
피험자 모집 중2상
18세 이상 · 모든 성별 · 2026. 10. 1. 업데이트됨 · NCT06649812

A Study to Compare How Well Odronextamab Combined With Chemotherapy Works and How Safe it is Against Rituximab Combined With Chemotherapy, in Adult Patients With Previously Untreated Diffuse Large B-cell Lymphoma

  • Indiana University Melvin and Bren Simon Comprehensive Cancer Center, Indianapolis
  • St Vincent Ascension at Peyton Manning Childrens Hospital, Indianapolis
  • Investigative Clinical Research of Indiana, Noblesville
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 9. 25. 업데이트됨 · NCT06091865

A Study to Evaluate Zilovertamab Vedotin (MK-2140) Combination With Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (R-CHOP) in Participants With Previously Untreated DLBCL (MK-2140-010)

  • Fort Wayne Medical Oncology and Hematology ( Site 0149), Fort Wayne
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 9. 25. 업데이트됨 · NCT06717347

Consolidation of First-Line MRD+ Remission With Cema-cel in Patients With LBCL

  • Fort Wayne Medical Oncology and Hematology, Fort Wayne
  • IU Simon Comprehensive Cancer Center, Indianapolis
  • Indiana Blood and Marrow Transplantation, Indianapolis
피험자 모집 중2상
18세 이상 · 모든 성별 · 2026. 8. 31. 업데이트됨 · NCT06500273

Study of Rondecabtagene Autoleucel in Aggressive Large B-Cell Lymphoma

  • Indiana Blood and Marrow Transplantation, Indianapolis
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2026. 8. 25. 업데이트됨 · NCT05826535

Safety and Efficacy of Epcoritamab With Gemcitabine, Dexamethasone, and Cisplatin (GDP) Salvage Chemotherapy in Relapsed Refractory Large B-cell Lymphoma

  • Indiana University Melvin and Bren Simon Comprehensive Cancer Center, Indianapolis
피험자 모집 중2상
18세 이상 · 모든 성별 · 2026. 7. 10. 업데이트됨 · NCT05852717

Study Adding Drugs to Usual Treatment for Large B-Cell Lymphoma That Returned or Did Not Respond to Treatment

  • Northwest Cancer Center - Main Campus, Crown Point
  • Northwest Oncology LLC, Dyer
  • Northwest Cancer Center - Hobart, Hobart
  • 외 5개
피험자 모집 중2상
18세 이상 · 모든 성별 · 2025. 10. 20. 업데이트됨 · NCT05890352

DPX-Survivac and Pembrolizumab With and Without Intermittent Low-Dose Cyclophosphamide, in Subjects With Relapsed/Refractory Diffuse Large B-Cell Lymphoma

  • Indiana University Health Melvin and Bren Simon Cancer Center, Indianapolis
피험자 모집 중2상
18세 이상 · 모든 성별 · 2023. 4. 7. 업데이트됨 · NCT04920617

Safety and Efficacy of KRT-232 in Combination With Acalabrutinib in Subjects With R/R DLBCL or R/R CLL

  • Goshen Center for Cancer Care, Goshen
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2022. 8. 4. 업데이트됨 · NCT04502394

ClinicalTrials.gov 출처, 2026. 10. 2. 기준 데이터입니다. 각 연구는 자체적인 자격 기준을 설정하며, 연구 팀이 참여자를 결정합니다.